FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a pharmaceutical vaginal composition for reducing or relieving uterine dysrhythmia. The composition contains an antidysrhythmia drug in the concentration of 1 wt % to 12.5 wt % and a pharmaceutically acceptable carrier providing prolonged release. The carrier contains a bioadhesive, water-swellable, water-insoluble, cross-linked polycarboxylic acid polymer such as polycarbophil. The drug is specified in prilocaine, mepivacaine, bupivacaine, ropivacaine, ethidocaine, mexiletine, procainamide, moracizin, propaphenone and flecainide.
EFFECT: invention provides reducing or relieving uterine dysrhythmia with prolonged release of said drugs with creating adequate local concentrations and low blood concentrations.
9 cl, 33 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITIONS OF PROLONGED CONTROLLED RELEASE, CONTAINING CHARGED POLYMERS | 2003 |
|
RU2366410C2 |
| VAGINAL ANTIARRHYTHMIC AGENTS FOR PELVIC PAIN TREATMENT | 2002 |
|
RU2345758C2 |
| LOW-CONCENTRATED PEROXIDE FOR TREATMENT OR PREVENTION OF VAGINAL INFECTIONS | 2002 |
|
RU2329829C2 |
| METHOD FOR TREATMENT OF ENDOMETRIOSIS OR INFERTILITY, OR IMPROVING OF FERTILITY AND PHARMACEUTICAL COMPOSITION THEREFOR | 2000 |
|
RU2310474C2 |
| TREATING VAGINAL ATROPHY IN FEMALES AT RISK OF TUMORAL PATHOLOGY | 2009 |
|
RU2504381C2 |
| MEDICINAL FORM COMPOSITION FOR TREATMENT OF VENEREAL DISEASES AND UTILIZATION THEREOF | 1995 |
|
RU2157184C2 |
| NEW METHOD OF DELIVERY OF PROGESTERONE AND ITS EFFECT | 1994 |
|
RU2148393C1 |
| HERBAL COMPOSITIONS FOR TREATING ORAL DISEASES | 2007 |
|
RU2450819C2 |
| METHOD FOR MANAGING NEUROPATHIC PAIN | 2010 |
|
RU2554494C2 |
| TREATMENT OF VAGINAL ATROPHY IN WOMEN WITH RISK OF CARDIOVASCULAR PATHOLOGY | 2009 |
|
RU2555752C2 |
